The MURDOCK Study Registry and Biorepository Horizon 1.5
NCT01708408 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50000
Last updated 2026-02-04
Summary
The MURDOCK Study Community Registry and Biorepository (Horizon 1.5) aims to create a large-scale community registry and biorepository that can be used as a vehicle for future health services, epidemiologic, clinical trials and other omics-related research.
Conditions
- Chronic Disease
- Healthy Volunteers
Interventions
- GENETIC
-
Biomarker studies
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Kristin M Newby, MD · Duke University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-02-28
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
NCT03871816 ·Status: COMPLETED
-
The BARCODE 1 Pilot Study
NCT03158922 ·Status: ACTIVE_NOT_RECRUITING
-
Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer
NCT01198171 ·Status: COMPLETED
-
The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.
NCT03857477 ·Status: ACTIVE_NOT_RECRUITING
-
Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection
NCT06895551 ·Status: COMPLETED
-
A Registry for Hereditary Cancer Risk Assessment and Genetic Testing
NCT04015102 ·Status: COMPLETED
-
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
NCT05390827 ·Status: RECRUITING
-
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
NCT07270666 ·Status: RECRUITING ·Phase: NA
-
Studies of Neurological Paraneoplastic Syndromes
NCT00587106 ·Status: COMPLETED
-
Biomarker Research for Personalized Medicine
NCT01488591 ·Status: UNKNOWN
-
Validation of the Stability of Diagnostic Biomarkers on Healthy Volunteers
NCT05160337 ·Status: RECRUITING ·Phase: NA
-
Concordance Between ctDNA Assay and FoundationOne
NCT02620527 ·Status: COMPLETED
-
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
NCT06482073 ·Status: RECRUITING
-
Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study
NCT06304168 ·Status: RECRUITING
-
NSABP Patient Registry and Biospecimen Profiling Repository
NCT01793805 ·Status: COMPLETED
-
Molecular and Genomic Profiling of Head and Neck Tumors
NCT00200486 ·Status: RECRUITING
-
Mayo Clinic Tapestry 2.0: Applying Multi-Omics for Scientific Discovery
NCT06456320 ·Status: ENROLLING_BY_INVITATION
-
Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Multiple Myeloma
NCT05693012 ·Status: UNKNOWN
-
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance
NCT06653062 ·Status: RECRUITING
-
Molecular Analysis of Blood Samples in Standardized Cancer Care Referrals for SCAN and CUP
NCT04025970 ·Status: UNKNOWN
-
Multicenter Tissue Registry in Melanoma
NCT05750511 ·Status: UNKNOWN
-
Molecular Markers in Cancers and Precancers (MOCA)
NCT05257707 ·Status: WITHDRAWN ·Phase: NA
-
Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions
NCT01457196 ·Status: COMPLETED ·Phase: NA
-
Wearable Devices and Biomarkers Project (Healthiomics)
NCT05106725 ·Status: RECRUITING
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED